GENEVA, Switzerland and TORONTO, Canada – AB SCIEX, a global leader in life science analytical technologies, and Geneva Bioinformatics (GeneBio) SA today announced that they will co-market joint solutions to improve the ability of scientists to conduct rapid screening of large sets of molecules. GeneBio’s SmileMS software provides advanced library searching capabilities that can be […]
MENLO PARK, Calif. – SwitchGear Genomics Inc., a leading provider of products for studying the regulatory elements in the human genome, today announced that the company signed an agreement for BioCat GmbH to distribute the innovative LightSwitch Luciferase Assay System(TM) in Europe. The system consists of a full reporter assay solution including a genome-wide collection […]
BILLERICA, MA, (February 8, 2011) – Aushon BioSystems, Inc., a leading provider of multiplex immunoassay products and services announced that it has signed a letter of intent to enter into a diagnostic development collaboration with Peking University Cancer Hospital (“PUCH”), Beijing, China. The primary goal for the collaboration is to develop predictive diagnostic markers for […]
Fort Collins, CO, USA – InVitria announces that its Lysobac cell lysing reagent is manufactured at the Company’s Junction City, Kansas facility under cGMP (Current Good Manufacturing Practice) standards. Lysobac is a completely animal component free reagent that is substantially more effective and consistent than hen egg white lysozyme and complies with global regulatory standards […]
Ithaca, N.Y. – Rheonix, Inc. today announced the receipt of a Small Business Innovation Research (SBIR) Phase II grant in the amount of $500,000 from the National Science Foundation (NSF) to continue development of a Rheonix CARD® (Chemistry and Reagent Device) system to detect certain types of water contamination. NSF awarded the grant based upon […]
AARHUS, Denmark & BUDAPEST, Hungary – Today, CLC bio and Omixon announced the release of the Omixon Gapped SOLiD Alignment plug-in for full integration into CLC Genomics Workbench. CLC bio is a leader in algorithm performance and provides an integrated solution for high-throughput sequencing data analysis, and Omixon is a leader in variant detection accuracy […]
Walkersville, MD. – Lonza and California Stem Cell, Inc. are pleased to announce the first commercially available source of motor neuron progenitors derived from human embryonic stem cells. The MotorPlate™ Human ESC-derived Motor Neuron Progenitor products are functional, adherent motor neuron progenitors seeded in 96-well plates and shipped to customers fresh and ready-to-use with optimized […]
CHICAGO – Baird Venture Partners (BVP), the U.S.-based venture capital fund of Baird Private Equity, announced today that its portfolio company Accuri Cytometers (Accuri) has signed a definitive agreement to be acquired by Becton, Dickinson and Company (BD) (NYSE: BDX), a leading global medical technology company. The acquisition is subject to regulatory approvals and is […]
BEDFORD, Mass. – Rapid Micro Biosystems, a leading provider of automated, non-destructive, rapid microbial detection, today announced a sales and marketing agreement with Life Technologies Corporation, a provider of innovative life science solutions. For quality control microbiology customers, the agreement combines best in class automated microbial detection and enumeration with gold-standard microbial identification. The agreement […]
Washington, D.C. – Danaher Corporation (NYSE:DHR) announced today that it has entered into a definitive merger agreement with Beckman Coulter, Inc. (NYSE: BEC) pursuant to which Danaher will acquire Beckman Coulter by making a cash tender offer to acquire all of the outstanding shares of common stock of Beckman Coulter at a purchase price of […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
